The function and biological role of toll-like receptors in infectious diseases: An update

Current Opinion in Infectious Diseases

Volumn 21, Issue 3, 2008, Pages 304-312

  Hornef, Mathias W ^a,b   Henriques Normark, Birgitta ^b,c   Normark, Staffan ^b,c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cellular microbiology; Immunology; Innate immunity; Microbial pathogenesis; Toll like receptor

Indexed keywords

TOLL LIKE RECEPTOR;

CARCINOGENESIS; DISEASE ASSOCIATION; HOST RESISTANCE; IMMUNOCOMPETENT CELL; INFECTION; INFLAMMATION; NONHUMAN; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; COMMUNICABLE DISEASES; GRAM-NEGATIVE AEROBIC RODS AND COCCI; GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS; HUMANS; IMMUNITY, NATURAL; NEOPLASMS; TOLL-LIKE RECEPTORS;

EID: 42949142061     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/QCO.0b013e3282f88ba3     Document Type: Review

References (104)

1. Tenor JL, Aballay A. A conserved Toll-like receptor is required for Caenorhabditis elegans innate immunity. EMBO Rep 2008; 9:103-109.
2. Pradel E, Zhang Y, Pujol N, et al. Detection and avoidance of a natural product from the pathogenic bacterium Serratia marcescens by Caenorhabditis elegans. Proc Natl Acad Sci U S A 2007; 104:2295-2300. A striking phenotype linking innate immune recognition to avoidance behavior and thereby restriction of pathogen exposure.
3. Wang X, Ribeiro AA, Guan Z, et al. Attenuated virulence of a Francisella mutant lacking the lipid A 4′-phosphatase. Proc Natl Acad Sci U S A 2007; 104:4136-4141.
4. Montminy SW, Khan N, McGrath S, et al. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nat Immunol 2006; 7:1066-1073.
5. Jin MS, Kim SE, Heo JY, et al. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 2007; 130:1071-1082.
6. Kim HM, Park BS, Kim JI, et al. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 2007; 130:906-917.
7. Andersen-Nissen E, Smith KD, Bonneau R, et al. A conserved surface on Toll-like receptor 5 recognizes bacterial flagellin. J Exp Med 2007; 204:393-403.
8. Latz E, Verma A, Visintin A, et al. Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Nat Immunol 2007; 8:772-779.
9. Teghanemt A, Prohinar P, Gioannini TL, Weiss JP. Transfer of monomeric endotoxin from MD-2 to CD14: characterization and functional consequences. J Biol Chem 2007; 282:36250-36256.
10. Prohinar P, Re F, Widstrom R, et al. Specific high affinity interactions of monomeric endotoxin protein complexes with Toll-like receptor 4 ectodomain. J Biol Chem 2007; 282:1010-1017.
11. Lundberg AM, Drexler SK, Monaco C, et al. Key differences in TLR3/poly I:C signaling and cytokine induction by human primary cells: a phenomenon absent from murine cell systems. Blood 2007; 110:3245-3252. Potentially very important finding indicating differences between mouse models and the human innate immune system.
12. Lichtinger M, Ingram R, Hornef M, et al. Transcription factor PU.1 controls transcription start site positioning and alternative TLR4 promoter usage. J Biol Chem 2007; 282:26874-268783. Potentially very important finding indicating differences between mouse models and the human innate immune system.
13. Vogel T, Tenbrock K, Ludwig S, et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 2007; 13:1042-1049.
14. Tsan MF, Gao B. Endogenous ligands of Toll-like receptors. J Leukoc Biol 2004; 76:514-519.
15. Coban C, Ishii KJ, Kawai T, et al. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J Exp Med 2005; 201:19-25.
16. Parroche P, Lauw FN, Goutagny N, et al. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc Natl Acad Sci U S A 2007; 104:1919-1924. This work impressively illustrates the potential problems encountered with impurities in preparative samples but also demonstrates unexpected effects of microbial infection on innate immune recognition.
17. Figueiredo RT, Fernandez PL, Mourao-Sa DS, et al. Characterization of heme as activator of Toll-like receptor 4. J Biol Chem 2007; 282:20221-20229.
18. Rowe DC, McGettrick AF, Latz E, et al. The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction. Proc Natl Acad Sci U S A 2006; 103:6299-6304.
19. Piao W, Song C, Chen H, et al. Tyrosine phosphorylation of MyD88 adapter-like (Mal) is critical for signal transduction and blocked in endotoxin tolerance. J Biol Chem 2008; 283:3109-3119.
20. Sarkar SN, Elco CP, Peters KL, et al. Two tyrosine residues of Toll-like receptor 3 trigger different steps of NF-kappa B activation. J Biol Chem 2007; 282:3423-3427.
21. Medvedev AE, Piao W, Shoenfelt J, et al. Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance. J Biol Chem 2007; 282:16042-16053.
22. Goto A, Matsushita K, Gesellchen V, et al. Akirins are highly conserved nuclear proteins required for NF-kappaB-dependent gene expression in drosophila and mice. Nat Immunol 2008; 9:97-104.
23. Zager RA, Johnson AC, Lund S, Randolph-Habecker J. Toll-like receptor (TLR4) shedding and depletion: acute proximal tubular cell responses to hypoxic and toxic injury. Am J Physiol Renal Physiol 2007; 292:F304-F312.
24. Husebye H, Halaas ∅, Stenmark H, et al. Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity. EMBO J 2006; 25:683-692.
25. Wang Y, Chen T, Han C, et al. Lysosome-associated small Rab GTPase Rab7b negatively regulates TLR4 signaling in macrophages by promoting lysosomal degradation of TLR4. Blood 2007; 110:962-971.
26. Bachmaier K, Toya S, Gao X, et al. E3 ubiquitin ligase Cblb regulates the acute inflammatory response underlying lung injury. Nat Med 2007; 13:920-926.
27. An H, Zhao W, Hou J, et al. SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production. Immunity 2006; 25:919-928.
28. Rothlin CV, Ghosh S, Zuniga EI, et al. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 2007; 131:1124-1136.
29. Miggin SM, Pålsson-McDermott E, Dunne A, et al. NF-kappaB activation by the Toll-IL-1 receptor domain protein MyD88 adapter-like is regulated by caspase-1. Proc Natl Acad Sci U S A 2007; 104:3372-3377. The presented data might help to explain the phenotype of Caspase 1-deficient mice in bacterial infection models.
30. Lemmers B, Salmena L, Bidère N, et al. Essential role for caspase-8 in Toll-like receptors and NFkappaB signaling. J Biol Chem 2007; 282:7416-7423.
31. Hara H, Ishihara C, Takeuchi A, et al. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nat Immunol 2007; 8:619-629.
32. Carmody RJ, Ruan Q, Palmer S, et al. Negative regulation of toll-like receptor signaling by NF-kappaB p50 ubiquitination blockade. Science 2007; 317:675-678.
33. Gringhuis SI, den Dunnen J, Litjens M, et al. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. Immunity 2007; 26:605-616.
34. Foster SL, Hargreaves DC, Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 2007; 447:972-978.
35. Lee HK, Lund JM, Ramanathan B, et al. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 2007; 315:1398-1401. Autophagy is a mechanism that is able to transfer molecules from the cytosol to endosomal compartments and therefore facilitates recognition by a broader set of innate immune receptors.
36. Xu Y, Jagannath C, Liu XD, et al. Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity 2007; 27:135-144.
37. Wang JP, Asher DR, Chan M, et al. Cutting edge: antibody-mediated TLR7-dependent recognition of viral RNA. J Immunol 2007; 178:3363-3367.
38. Herskovits AA, Auerbuch V, Portnoy DA. Bacterial ligands generated in a phagosome are targets of the cytosolic innate immune system. PLoS Pathog 2007; 3:e51. In the outcome similar to ligand translocation reported for Helicobacter pylori (via the bacterial type IV secretion system) or Salmonella enterica (via the bacterial type III secretion system). Widens the spectrum of receptors involved in recognition.
39. Sun YH, Rolán HG, Tsolis RM. Injection of flagellin into the host cell cytosol by Salmonella enterica serotype Typhimurium. J Biol Chem 2007; 282: 33897-33901.
40. Rhee SH, Im E, Riegler M, et al. Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation. Proc Natl Acad Sci U S A 2005; 102:13610-13615.
41. Lee J, Mo JH, Katakura K, et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 2006; 8:1327-1336.
42. Ewaschuk JB, Backer JL, Churchill TA, et al. Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA. Infect Immun 2007; 75:2572-2579.
43. Barrionuevo P, Cassataro J, Delpino MV, et al. Brucella abortus inhibits major histocompatibility complex class II expression and antigen processing through interleukin-6 secretion via Toll-like receptor 2. Infect Immun 2008; 76:250-262.
44. Gavin AL, Hoebe K, Duong B, et al. Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science 2006; 314:1936-1938.
45. Schleicher U, Liese J, Knippertz I, et al. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. J Exp Med 2007; 204:893-906.
46. Akazawa T, Ebihara T, Okuno M, et al. Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells. Proc Natl Acad Sci U S A 2007; 104:252-257.
47. Paget C, Mallevaey T, Speak AO, et al. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 2007; 27:597-609.
48. Zhou R, Wei H, Sun R, et al. NKG2D recognition mediates Toll-like receptor 3 signaling-induced breakdown of epithelial homeostasis in the small intestines of mice. Proc Natl Acad Sci U S A 2007; 104:7512-7515.
49. Beiter K, Wartha F, Albiger B, et al. An endonuclease allows Streptococcus pneumoniae to escape from neutrophil extracellular traps. Curr Biol 2006; 16:401-407.
50. Wartha F, Beiter K, Normark S, Henriques-Normark B. Neutrophil extracellular traps: casting the NET over pathogenesis. Curr Opin Microbiol 2007; 10:52-56.
51. Clark SR, Ma AC, Tavener SA, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007; 13:463-469. Unexpected finding identifying a new role of platelets in antibacterial host defence.
52. Delano MJ, Scumpia PO, Weinstein JS, et al. MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med 2007; 204:1463-1474.
53. Fukata M, Chen A, Vamadevan AS, et al. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 2007; 133:1869-1881.
54. Huang B, Zhao J, Shen S, et al. Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling. Cancer Res 2007; 67:4346-4352.
55. Naugler WE, Sakurai T, Kim S, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007; 317:121-124.
56. Hasan UA, Caux C, Perrot I, et al. Cell proliferation and survival induced by Toll-like receptors is antagonized by type I IFNs. Proc Natl Acad Sci U S A 2007; 104:8047-8052.
57. Rakoff-Nahoum S, Medzhitov R. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 2007; 317: 124-127. This publication indicates a link of IL1/IL18R/TLR stimulation with cancerogenesis potentially independent of inflammation and inflammation-related DNA damage.
58. Morikawa T, Sugiyama A, Kume H, et al. Identification of Toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinoma. Clin Cancer Res 2007; 13:5703-5709.
59. Andreani V, Gatti G, Simonella L, et al. Activation of Toll-like receptor 4 on tumor cells in vitro inhibits subsequent tumor growth in vivo. Cancer Res 2007; 67:10519-10527. The effect observed is shown to T-cell-dependent demonstrating an instructive link from somatic cells to cells of the adaptive immune system
60. O'Connell RM, Taganov KD, Boldin MP, et al. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 2007; 104:1604-1609.
61. Schmidt C. Clinical setbacks for toll-like receptor 9 agonists in cancer. Nat Biotechnol 2007; 25:825-826.
62. ••] this work nicely demonstrates the importance of NF-κB-signaling in nonmyeloid cells for maintenance of gut homeostasis.
63. ••] this work nicely demonstrates the importance of NF-κB-signaling in nonmyeloid cells for maintenance of gut homeostasis.
64. Brandl K, Plitas G, Schnabl B, et al. MyD88-mediated signals induce the bactericidal lectin RegIII gamma and protect mice against intestinal Listeria monocytogenes infection. J Exp Med 2007; 204:1891-1900.
65. Rosen DA, Hooton TM, Stamm WE, et al. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med 2007; 4:e329. This article demonstrates persistence of intracellular uropathogenic E. coli in human bladder epithelium identifying intracellular persistence as potentially important mechanism for recurrent UTI in humans.
66. Song J, Bishop BL, Li G, et al. TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder. Cell Host Microbe 2007; 1:287-298. This article illustrates an ill-defined cAMP concentration dependent TLR4-mediated antibacterial effect of epithelial cells.
67. Song J, Duncan MJ, Li G, et al. A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells. PLoS Pathog 2007; 3:e60.
68. Justice SS, Hunstad DA, Seed PC, Hultgren SJ. Filamentation by Escherichia coli subverts innate defenses during urinary tract infection. Proc Natl Acad Sci U S A 2006; 103:19884-19889.
69. Bishop BL, Duncan MJ, Song J, et al. Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells. Nat Med 2007; 13:625-630. Unexpected mechanism of immune evasion by uropathogenic bacteria in intracellular compartments specific for urothelial cells.
70. Gonen E, Vallon-Eberhard A, Elazar S, et al. Toll-like receptor 4 is needed to restrict the invasion of Escherichia coli P4 into mammary gland epithelial cells in a murine model of acute mastitis. Cell Microbiol 2007; 9:2826-2838.
71. Beisswenger C, Coyne CB, Shchepetov M, Weiser JN. Role of p38 MAP kinase and transforming growth factor-b signaling in transepithelial migration of invasive bacterial pathogens. J Biol Chem 2007; 282:28700-28708. The results of this work may ultimately help to explain why certain pathogens can asymptomatically colonize mucosal membranes and also cause invasive disease.
72. Khor CC, Chapman SJ, Vannberg FO, et al. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet 2007; 39:523-528.
73. Albiger B, Dahlberg S, Sandgren A, et al. Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection. Cell Microbiol 2007; 9:633-644.
74. Bhan U, Lukacs NW, Osterholzer JJ, et al. TLR9 is required for protective innate immunity in Gram-negative bacterial pneumonia: role of dendritic cells. J Immunol 2007; 179:3937-3946.
75. Shigeoka AA, Holscher TD, King AJ, et al. TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways. J Immunol 2007; 178: 6252-6258.
76. Wu H, Chen G, Wyburn KR, et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 2007; 117:2847-2859.
77. Chassin C, Hornef MW, Bens M, et al. Hormonal control of the renal immune response and antibacterial host defense by arginine vasopressin. J Exp Med 2007; 204:2837-2852. This article identifies vasopressin, a renal hormone regulating blood pressure and ion/water homeostasis as regulator of TLR4 signaling in renal epithelial cells. This finding might help to explain the clinical association between hypovolemia and UTI.
78. Hua F, Ha T, Ma J, et al. Protection against myocardial ischemia/reperfusion injury in TLR4-deficient mice is mediated through a phosphoinositide 3-kinase-dependent mechanism. J Immunol 2007; 178:7317-7324.
79. Leaphart CL, Cavallo J, Gribar SC, et al. A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J Immunol 2007; 179:4808-4820.
80. Aprahamian CJ, Lorenz RG, Harmon CM, Dimmit RA. Toll-like receptor 2 is protective of ischemia-reperfusion-mediated small-bowel injury in a murine model. Pediatr Crit Care Med 2008; 9:105-109.
81. Macedo L, Pinhal-Enfield G, Alshits V, et al. Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors. Am J Pathol 2007; 171:1744-1788. The link of MyD88 with wound healing cannot be underestimated and might contribute to the clinical phenotype in many kinds of animal experiments. Particularly, it might explain the strong phenotype observed in MyD88-deficient mice and their susceptibility to epithelial injury.
82. Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 2007; 132:1359-1374.
83. Gibson DL, Ma C, Rosenberger CM, et al. Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis. Cell Microbiol 2008; 10:388-403.
84. Meier A, Alter G, Frahm N, et al. MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands. J Virol 2007; 81:8180-8191.
85. Hardy AW, Graham DR, Shearer GM, Herbeuval JP. HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-alpha. Proc Natl Acad Sci U S A 2007; 104:17453-17458.
86. Martinelli E, Cicala C, Van Ryk D, et al. HIV-1 gp120 inhibits TLR9-mediated activation and IFN-a secretion in plasmacytoid dendritic cells. Proc Natl Acad Sci U S A 2007; 104:3396-3401.
87. Bochud PY, Hersberger M, Taffé P, et al. Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. AIDS 2007; 21:441-446.
88. Kim TW, Staschke K, Bulek K, et al. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity. J Exp Med 2007; 204:1025-1036.
89. Kawagoe T, Sato S, Jung A, et al. Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor-mediated immune responses but not in TCR signaling. J Exp Med 2007; 204:1013-1024.
90. Ku CL, von Bernuth H, Picard C, et al. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med 2007; 204:2407-2422. Surprising results indicating a particularly important role of TLR signalling and innate immune recognition-mediated host defence activation in children.
91. Hawn TR, Misch EA, Dunstan SJ, et al. A common human TLR1 polymorphism regulates the innate immune response to lipopeptides. Eur J Immunol 2007; 37:2280-2289.
92. Thuong NT, Hawn TR, Thwaites GE, et al. A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis. Genes Immun 2007; 8:422-428.
93. Ma X, Liu Y, Gowen BB, et al. Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease. PLoS ONE 2007; 2:e1318.
94. Pathak SK, Basu S, Basu KK, et al. Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages. Nat Immunol 2007; 8:610-618.
95. Ferwerda B, Kibiki GS, Netea MG, et al. The toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania. AIDS 2007; 21:1375-1377.
96. Casrouge A, Zhang SY, Eidenschenk C, et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 2006; 314:308-312.
97. Brinkmann MM, Spooner E, Hoebe K, et al. The interaction between the ER membrane protein UNC93B and TLR3 7 and 9 is crucial for TLR signaling. J Cell Biol 2007; 177:265-275.
98. Zhang SY, Jouanguy E, Ugolini S, et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007; 317:1522-1527. This article together with the publications of Casrouge et al. [96] and Brinkmann et al. [97] clearly demonstrate the important role of TLR3 for control of HSV-1 in central nervous tissue.
99. Ferwerda B, McCall MB, Alonso S, et al. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc Natl Acad Sci U S A 2007; 104:16645-16650.
100. McCall MB, Netea MG, Hermsen CC, et al. Plasmodium falciparum infection causes proinflammatory priming of human TLR responses. J Immunol 2007; 179:162-171. The described effect might significantly contribute to the clinical course of patients with malaria.
101. Lepenies B, Cramer JP, Burchard GD, et al. Induction of experimental cerebral malaria is independent of TLR2/4/9. Med Microbiol Immunol 2008; 197:39-44.
102. Togbe D, Schofield L, Grau GE, et al. Murine cerebral malaria development is independent of toll-like receptor signaling. Am J Pathol 2007; 170:1640-1648.
103. Mockenhaupt FP, Cramer JP, Hamann L, et al. Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria. J Commun Dis 2006; 38:230-245.
104. Feterowski C, Emmanuilidis K, Miethke T, et al. Effects of functional Toll-like receptor-4 mutations on the immune response to human and experimental sepsis. Immunology 2003; 109:426-431.